SHMARQL

dextroamphetamine

<http://www.wikidata.org/entity/Q1706418>

pharmaceutical drug
rdfs:label
"dextroamphetamine"@en
skos:altLabel
"(+)-(S)-amphetamine"@en
"(+)-Amphetamine"@en
"(+)-alpha-Methylphenethylamine"@en
"(+)-alpha-Methylphenylethylamine"@en
"(AlphaS)-alpha-methylbenzeneethanamine"@en
"(S)-(+)-Amphetamine"@en
"(S)-(+)-beta-Phenylisopropylamine"@en
"(S)-1-Phenyl-2-aminopropane"@en
"(S)-1-Phenyl-2-propylamine"@en
"(S)-alpha-Methylbenzeneethanamine"@en
"(S)-amphetamine"@en
"Dexamfetamine"@en
"Dexedrine"@en
"Dextroamphetamine"@en
"Dextrostat"@en
"d-amphetamine"@en
"dexamphetamine"@en
schema:description
"pharmaceutical drug"@en
schema:dateModified "2026-09-28T07:39:00+00:00"^^xsd:dateTime
schema:version 2550378048
wikibase:identifiers 44
wikibase:sitelinks 34
wikibase:statements 94
p:P10245 wd:statement/Q1706418-257294f5-48bc-1e0f-adce-051bf2ed42ee
p:P10283 wd:statement/Q1706418-838DB89A-F885-4F4B-B2E5-EE8CDF36B1BE
p:P11089 wd:statement/Q1706418-16AB3D82-C56D-4D5B-959A-95128A6C9455
p:P11143 wd:statement/Q1706418-4658C423-BC8D-4056-B945-06AED247FD46
p:P11198 wd:statement/Q1706418-3F7A22B8-90EA-41C5-8C2C-B2157C6A88C7
p:P11199 wd:statement/Q1706418-5CEE90D1-9CEE-4A34-9FF3-63E51EF72FCE
p:P117 wd:statement/Q1706418-02D5BCDE-115E-4B1B-A36C-229017B20BAF
p:P129 wd:statement/Q1706418-52E063FC-CD00-43E1-9C2D-08A3C3D3FE70
wd:statement/Q1706418-78E7ABC4-CB2A-4FC2-B75E-D820E0B0ECAD
wd:statement/Q1706418-AF750987-53E7-4FC6-9B3E-D0CACF12F00C
wd:statement/Q1706418-B83C0CE2-6FFF-4D47-8C1B-B084F634D702
wd:statement/Q1706418-BA6C62E1-DB55-49B5-A8E9-B9F44AF27DEE
wd:statement/Q1706418-F417B256-0D2E-4C49-95C3-7EEB57C03E74
wd:statement/Q1706418-F6615177-54F0-4B20-9E94-200FA24F04BD
p:P13204 wd:statement/Q1706418-AB2B2B56-22C4-4987-8F95-44B0FF37FDB0
p:P1343 wd:statement/Q1706418-4B0D6860-A03C-4845-814F-7FC80123CD5B
p:P1417 wd:statement/Q1706418-B0907C1C-2BE1-447A-A75E-DB695CE3E3BD
p:P14834 wd:statement/Q1706418-7CECC613-2F45-422C-9AEC-52A9AFA41A33
wd:statement/Q1706418-C70C8210-54B0-48BD-858D-6574E302C34B
wd:statement/Q1706418-DF794318-7FD7-474C-9035-A0CE1A262ABB
wd:statement/Q1706418-E1D60535-B0D3-4ED6-B37B-6240B78D1D80
wd:statement/Q1706418-E8254AF3-80DF-486D-94EA-14DEE769E6C7
wd:statement/Q1706418-F6AC0AAE-FD13-41E7-9A80-F2E0417165FD
p:P1578 wd:statement/Q1706418-EA0BA749-815E-4293-85DD-C71844D8AFAC
p:P1579 wd:statement/Q1706418-432A553D-12CB-43E6-857D-5CAFFE99725E
p:P2017 wd:statement/Q1706418-E8E4ECE8-339A-4C99-BC64-B04755EF822A
p:P2057 wd:statement/Q1706418-E946CA4F-D0D0-4116-B0CC-BEA1CE3DC24A
p:P2062 wd:statement/Q1706418-6792528E-0FAF-4389-B80F-EB710431385F
p:P2067 wd:statement/Q1706418-4664E9A2-6BD5-42FD-80B1-B47CD8D1F751
p:P2115 wd:statement/Q1706418-F8E75745-F8F3-4DEA-A209-28EA74FE13CB
p:P2175 wd:statement/Q1706418-904B8F30-9FDB-48A7-94F9-33EE2AAE393B
wd:statement/Q1706418-CDF36D2F-D270-4562-A93D-4AE102F6714B
wd:statement/Q1706418-DD975EAD-78C2-47C8-89DD-B10873E33CCF
p:P2275 wd:statement/Q1706418-850E9CDF-FAFB-417E-9EB5-A292D9406675
p:P231 wd:statement/Q1706418-BD0DEEC1-794A-4444-92D3-C846FB8F6700
p:P232 wd:statement/Q1706418-021C8422-70FD-45B5-985F-450D58700BEE
p:P233 wd:statement/Q1706418-2C8DAD02-42FF-4964-A39F-235FC1142C97
p:P234 wd:statement/Q1706418-A66D06F0-A731-4AE0-B091-A6051F6DE1C2
p:P235 wd:statement/Q1706418-F9A2EE26-3FA5-4A82-A0A2-9A44C2DA87A2
p:P2566 wd:statement/Q1706418-13572468-2468-1357-eca9-bdf024681357
p:P267 wd:statement/Q1706418-63E9D6C1-DC91-4935-BFC4-DDE5B950B75F
p:P274 wd:statement/Q1706418-961B98D0-7ACE-4E47-9A81-69E2CC3D67A9
p:P279 wd:statement/Q1706418-8E5F5078-4040-40BA-93D9-B3959009665C
p:P2840 wd:statement/Q1706418-30608DA6-8745-4D35-B1A3-D517DD23F7F7
p:P2868 wd:statement/Q1706418-3D3E96A0-C58B-43B4-98C7-93AB47845805
wd:statement/Q1706418-A54C68D0-0210-404B-991C-8976E2FB21E9
wd:statement/Q1706418-A9C152D2-63EE-4187-A490-F07557AB1E37
wd:statement/Q1706418-E6D13382-1BC7-429A-9D30-40FD29C33D53
wd:statement/Q1706418-FA66AD49-6584-451A-9C6E-2E779E3E7530
p:P2877 wd:statement/Q1706418-547DE30B-D277-4BDD-847A-E60CAFCBBF35
p:P2892 wd:statement/Q1706418-BDBF499C-ECFF-4001-919D-E72CA7795FEC
p:P31 wd:statement/Q1706418-B91BFFB8-B2D8-4643-BCC0-9FCE96F65FF8
p:P3117 wd:statement/Q1706418-306F6818-3E3E-40D4-8915-5F657AB880CF
p:P3345 wd:statement/Q1706418-A490775F-5D32-494C-B77A-0AF9C9AE945D
p:P3350 wd:statement/Q1706418-6e1462c5-44f6-f79e-850c-084de2513a0e
p:P3364 wd:statement/Q1706418-6cf64f7a-4d3e-6de8-0584-c80883d99f47
p:P3417 wd:statement/Q1706418-293F6228-E340-40FB-BD5C-685D0622F437
p:P3489 wd:statement/Q1706418-019B5D59-C5E6-4033-9BAE-12BF2BCF59E1
wd:statement/Q1706418-620B74E0-A423-4E2D-871A-50161E9841A2
p:P3493 wd:statement/Q1706418-8DEAA4AB-1B02-43B2-A28C-A4C5C5CD358A
p:P3636 wd:statement/Q1706418-9a3a80cc-424b-8965-3972-5aa4fefa0921
p:P366 wd:statement/Q1706418-579566C7-A0B9-41ED-8177-9914961C650B
p:P373 wd:statement/Q1706418-c8e3abe9-474d-358f-4d21-475130913b39
p:P3780 wd:statement/Q1706418-371e35fd-441b-e0c1-255d-e78260bee7c4
wd:statement/Q1706418-4D1809AB-2630-4F13-B810-A949A59251B8
wd:statement/Q1706418-670DFF8C-34E2-4704-B577-8C78CC1C8A5E
wd:statement/Q1706418-F3BB300E-684F-4843-BFFA-33B6B3ADEDEB
p:P4168 wd:statement/Q1706418-9DBA0927-201F-43CC-892B-D427D69F48B2
p:P4250 wd:statement/Q1706418-1154267F-A35E-48D1-B13B-5F3F544A085E
p:P486 wd:statement/Q1706418-26825430-6D0F-4206-BBC7-4B595B613BDF
p:P4964 wd:statement/Q1706418-8E84D92B-5246-4D2D-BB85-BDE745DD6BA6
p:P527 wd:statement/Q1706418-1B63A09F-9CB5-40CE-B33D-413E15F425BB
wd:statement/Q1706418-7F7797ED-E57D-4772-9DEA-4156B1DF79D3
wd:statement/Q1706418-b576a1a2-4cf3-9150-87fa-e08e6706969a
p:P592 wd:statement/Q1706418-B90FFD66-278A-4016-9C19-B91FA8A10707
p:P595 wd:statement/Q1706418-E12CF8C9-11A5-46C9-84DD-D8E6F6A65DF9
p:P6366 wd:statement/Q1706418-52939ED4-F3FC-4644-BE49-0F75A3E322B0
p:P646 wd:statement/Q1706418-AB93C584-468E-4D88-AA7E-104A8B75A024
p:P652 wd:statement/Q1706418-AB04813F-C8F5-40FC-B06A-14B073709BD6
p:P661 wd:statement/Q1706418-E31EE30C-39C0-4F26-8948-DEAE38353700
p:P662 wd:statement/Q1706418-6042EA62-198D-4668-A08F-5A6FF492225E
p:P665 wd:statement/Q1706418-2C299819-920C-44A6-AD2B-83D41C7DD4A0
p:P6694 wd:statement/Q1706418-374F93C9-0A77-4794-ABCE-32E985A63566
p:P672 wd:statement/Q1706418-8dcc6d81-47e8-018e-8864-328f9f191f37
p:P683 wd:statement/Q1706418-A5BE77F1-ADA0-4FA6-A685-A0A4B34A64BA
p:P703 wd:statement/Q1706418-D77F733D-2037-4CEC-ABBF-252E933F5800
p:P715 wd:statement/Q1706418-5117B6BB-CDEF-4B37-B67B-9CC8DB5CAFBB
p:P769 wd:statement/Q1706418-09DA7137-978A-4A65-AA57-0206B8AD6AFA
wd:statement/Q1706418-26E3CF2D-1070-450A-8C61-168F1B1209EF
wd:statement/Q1706418-341D34A7-97AC-41C3-80A9-4AE50D956C3F
wd:statement/Q1706418-A87C71D9-68EA-404B-B94A-ECC3F307FC16
wd:statement/Q1706418-FF58B1A2-822A-45DD-9FDB-80856156D0ED
p:P8494 wd:statement/Q1706418-DA2E4E36-50ED-49D7-B0D3-74D23B04BC40
p:P9272 wd:statement/Q1706418-C9127FD0-5151-4723-A436-147EE9EF6ADA
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148062>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/D003913>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL612>
p:direct-normalized/P6366 <https://makg.org/entity/2776145449>
p:direct-normalized/P661 <http://rdf.chemspider.com/5621>
p:direct-normalized/P662 <http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5826>
p:direct-normalized/P665 <http://www.kegg.jp/entry/C07884>
p:direct-normalized/P6694 <http://id.nlm.nih.gov/mesh/M0006134>
p:direct-normalized/P672 <http://id.nlm.nih.gov/mesh/D02.092.471.683.152.110.200>
p:direct-normalized/P683 <http://purl.obolibrary.org/obo/CHEBI_4469>
wdt:P10245 "a605027"
wdt:P10283 "C2776145449"
wdt:P11089 "169350"
wdt:P11143 "Dextroamphetamine"
wdt:P11198 "841"
wdt:P11199 "PD009473"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/D-amphetamine.svg>
wdt:P129 Trace amine associated receptor 1
Trace amine-associated receptor 1
solute carrier family 6 member 3
Solute carrier family 18 member A2
Solute carrier family 6 member 2
wdt:P13204 "cqq66343"
wdt:P1343 Opium Law
wdt:P1417 "science/dextroamphetamine"
wdt:P14834 Schedule I (Russia)
Class B (United Kingdom)
Schedule II (United States)
Anlage III (Germany)
Schedule II (Convention on Psychotropic Substances 1971)
Schedule 8 (Australia)
wdt:P1578 "1125854"
wdt:P1579 "2205872"
wdt:P2017 "C[C@@H](CC1=CC=CC=C1)N"
wdt:P2057 "HMDB0015516"
wdt:P2062 "3055"
wdt:P2067 135.104799^^xsd:decimal
wdt:P2115 "N0000148062"
wdt:P2175 attention deficit hyperactivity disorder
narcolepsy
wdt:P2275 "dexamfetamine"@en
wdt:P231 "51-64-9"
wdt:P232 "200-112-1"
wdt:P233 "CC(CC1=CC=CC=C1)N"
wdt:P234 "InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1"
wdt:P235 "KWTSXDURSIMDCE-QMMMGPOBSA-N"
wdt:P2566 "100.000.103"
wdt:P267 "N06BA02"
wdt:P274 "C₉H₁₃N"
wdt:P279 DL-amphetamine
wdt:P2840 "73713"
wdt:P2868 stimulant
monoamine oxidase inhibitor
nootropic
dopamine reuptake inhibitor
adrenergic uptake inhibitors
wdt:P2877 "8859"
wdt:P2892 "C0011812"
wdt:P31 type of chemical entity
wdt:P3117 "DTXSID8022907"
wdt:P3345 "3288"
wdt:P3350 "1430"
wdt:P3364 (R)-amphetamine
wdt:P3417 "Dexamphetamine"
wdt:P3489 US pregnancy category C
Australian pregnancy category B3
wdt:P3493 boxed warning
wdt:P3636 "1WE"
wdt:P366 medication
wdt:P373 "Dextroamphetamine"
wdt:P3780 Dexedrine
ProCentra
Zenzedi
Adderall
wdt:P4168 "224549"
wdt:P4250 15.0^^xsd:decimal
wdt:P486 "D003913"
wdt:P4964 "splash10-0006-9000000000-f40d32a5bced4783345a"
wdt:P527 hydrogen
carbon
nitrogen
wdt:P592 "CHEMBL612"
wdt:P595 "2147"
wdt:P6366 "2776145449"
wdt:P646 "/m/02dl34"
wdt:P652 "TZ47U051FI"
wdt:P661 "5621"
wdt:P662 "5826"
wdt:P665 "C07884"
wdt:P6694 "M0006134"
wdt:P672 "D02.092.471.683.152.110.200"
wdt:P683 "4469"
wdt:P703 Vachellia rigidula
wdt:P715 "DB01576"
wdt:P769 phenelzine
(±)-deprenyl
isocarboxazid
procarbazine
tranylcypromine
wdt:P8494 "DTXCID802907"
wdt:P9272 "3934"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata